including Johns Hopkins and the Mayo Clinic, to provide data to the FDA to prove that convalescent plasma is a safe and effective treatment for immunocompromised COVID-19 patients. Casadevall and ...

the Mayo Clinic, as well as others have been working on this approval for years. High Titer convalescent plasma was used as an "emergency treatment" for COVID-19 starting early on in the pandemic.

We've been hearing a lot about different treatments-- potential treatments-- for COVID-19. One we haven't heard that much about lately is convalescent plasma ... And now, Mayo Clinic is having ...

Studies have shown convalescent plasma from COVID-19 survivors contains antibodies with potent antiviral activity, but there are a lot of unanswered questions about use in patients, including the ...

The World Health Organization now strongly recommends against the use of convalescent plasma in the treatment of COVID-19 patients regardless of their stage of illness. This recommendation, announced ...

The Maui News / MATTHEW THAYER photo Convalescent plasma donations from recovered COVID-19 patients could save a life, a concept that officials say can help to treat those hospitalized with the virus.

White House officials hail convalescent plasma as a major breakthrough ... in part because the authorization was based on a handful of studies from the Mayo Clinic that failed to include appropriate ...

The small San Diego biotech developed the drug candidate after screening “convalescent” plasma from around ... therapy for COVID-19. Meanwhile, the Mayo Clinic and American Red Cross have ...